| http://www.w3.org/ns/prov#value | - Code) and the Office of Inspector General???s (OIG) Compliance Program Guidance for Pharmaceutical Manufacturers, if we are found not to be in full compliance with these laws, we could face enforcement action and fines and other penalties, and could receive adverse publicity.
|